Search Results
513 results
Your search is now limited to «Partnerships and Collaborations» expert search.
CB Insights - Blog 03/22/2019 12:58
Hi there, Here’s what went down in artificial intelligence this week. Top Deals Enterprise IT UiPath , a robotic process automation startup, reached a $7B valuation with its $400M Series D round, backed by Accel, Credo Ventures, Earlybird Venture Capital, and …. The post This Week In AI: UiPath Raises $400M, Merck Partners With Drug Design Startup, Google Creates First AI-Powered Doodle appeared first on CB Insights Research .
PharmaTimes 03/22/2019 09:13
The deal extends Exscientia’s list of partnerships with blue chip pharma and biotech companies, with existing collaborations already involving Roche, GSK, Sanofi and Evotec.
More from PharmaTimes:
ENDPOINTS 03/22/2019 06:21
Biogen partner launched a new PhIII before aducanumab was dead cold – Endpoints News.
More from ENDPOINTS:
WN.com 03/22/2019 03:40
LegoChem Biosciences entered research collaboration and license agreement with Takeda for antibody-drug conjugates development in immuno-oncology.
More from WN.com:
Merck Foundation also announces Call for Application for 'Merck More than a Mother' 'Media Recognition Awards' for Burundi and rest of Africa.
More from Middle East North Africa Financial Network (MENAFN):
Merck and NGM Biopharmaceuticals announced that Merck has exercised its option to extend the research phase of the companies’ broad, strategic collaboration for an additional two-year period from March 2020 to March 2022.
More from Pharmaceutical Business Review:
Johnson & Johnson 03/20/2019 21:30
The collaboration was facilitated by Johnson & Johnson Innovation.
More from Johnson & Johnson:
PR Newswire 03/20/2019 08:45
PLYMOUTH MEETING, Pa. and INDIANAPOLIS, March 20, 2019 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) and Eli Lilly and Company (NYSE: LLY) today announced six projects that aim to improve the delivery of gastric and gastroesophageal...
More from PR Newswire:
Bionity.com 03/20/2019 08:00
We are excited about the planned collaboration with Merck to better serve our local and overseas customers with cGMP manufacturing facilities, and to accelerate the drug commercialization process,” said Daniel Wang Dongliang, vice president of Operations, Biologics Department, at GenScript.
More from Bionity.com:
News-Medical.net 03/20/2019 05:51
Mar 20 2019 Merck, a leading science and technology company, today announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing.
More from News-Medical.net:
World Pharma News 03/19/2019 07:00
We are excited about the planned collaboration with Merck to better serve our local and overseas customers with cGMP manufacturing facilities, and to accelerate the drug commercialization process," said Daniel Wang Dongliang, vice president of Operations, Biologics Department, at GenScript.
More from World Pharma News:
Zacks.com 03/15/2019 16:25
The company will incorporate Lilly Pulitzer’s signature patterns and prints in their quality home furnishing collection.
More from Zacks.com:
Pharmafile 03/15/2019 07:45
Merck KGaA enters drug discovery partnership with AI firm Itkos.
More from Pharmafile:
In a short space of time, our technology has successfully enabled huge progress and we are eager to apply the enormous possibilities it holds to help Merck KGaA, Darmstadt, Germany with the successful design of new therapeutic options.
More from Global Banking & Finance Review:
Contract Pharma 03/14/2019 09:49
Merck KGaA has formed a collaboration agreement with Iktos for the use of its generative modelling artificial intelligence (AI) technology, in order to facilitate the rapid and cost-effective discovery and design of promising new compounds.
More from Contract Pharma:
Amgen News Release 03/12/2019 09:29
Comedian and television host Jay Leno has partnered with Amgen to motivate patients and caregivers to get in the driver's seat as it relates to their cholesterol management.
More from Amgen News Release:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications